{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:33:42Z","timestamp":1787582022723,"version":"build-2736575974"},"reference-count":31,"publisher":"The Endocrine Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,10,1]]},"DOI":"10.1210\/jc.2012-2037","type":"journal-article","created":{"date-parts":[[2012,10,6]],"date-time":"2012-10-06T15:38:15Z","timestamp":1349537895000},"page":"3759-3765","source":"Crossref","is-referenced-by-count":63,"title":["GADA Titer-Related Risk for Organ-Specific Autoimmunity in LADA Subjects Subdivided according to Gender (NIRAD Study 6)"],"prefix":"10.1210","volume":"97","author":[{"given":"Simona","family":"Zampetti","sequence":"first","affiliation":[{"name":"Department of Internal Medicine and Medical Specialties (S.Z., M.C., M.S., G.C., G.L., L.C., C.T., R.B.), \u201cSapienza\u201d University, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Capizzi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Medical Specialties (S.Z., M.C., M.S., G.C., G.L., L.C., C.T., R.B.), \u201cSapienza\u201d University, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marialuisa","family":"Spoletini","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Medical Specialties (S.Z., M.C., M.S., G.C., G.L., L.C., C.T., R.B.), \u201cSapienza\u201d University, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Campagna","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Medical Specialties (S.Z., M.C., M.S., G.C., G.L., L.C., C.T., R.B.), \u201cSapienza\u201d University, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Leto","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Medical Specialties (S.Z., M.C., M.S., G.C., G.L., L.C., C.T., R.B.), \u201cSapienza\u201d University, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Cipolloni","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Medical Specialties (S.Z., M.C., M.S., G.C., G.L., L.C., C.T., R.B.), \u201cSapienza\u201d University, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Tiberti","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Medical Specialties (S.Z., M.C., M.S., G.C., G.L., L.C., C.T., R.B.), \u201cSapienza\u201d University, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Bosi","sequence":"additional","affiliation":[{"name":"General Medicine, Diabetes, and Endocrinology (E.B.), San Raffaele Vita-Salute University, 20132 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Falorni","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine (A.F.), University of Perugia, 06123 Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Buzzetti","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Medical Specialties (S.Z., M.C., M.S., G.C., G.L., L.C., C.T., R.B.), \u201cSapienza\u201d University, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the NIRAD Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2019041115285031400_B1","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1464-5491.2007.02316.x","article-title":"The islet autoantibody titers: their clinical relevance in latent autoimmune diabetes in adults (LADA) and the classification of diabetes mellitus.","volume":"25","author":"van Deutekom","year":"2008","journal-title":"Diabet Med"},{"key":"2019041115285031400_B2","doi-asserted-by":"crossref","first-page":"932","DOI":"10.2337\/dc06-1696","article-title":"High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes.","volume":"30","author":"Buzzetti","year":"2007","journal-title":"Diabetes Care"},{"key":"2019041115285031400_B3","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1007\/s00125-007-0745-6","article-title":"GAD autoantibodies and epitope reactivities persist after diagnosis in latent autoimmune diabetes in adults but do not predict disease progression: UKPDS 77.","volume":"50","author":"Desai","year":"2007","journal-title":"Diabetologia"},{"key":"2019041115285031400_B4","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1530\/EJE-10-0427","article-title":"Number of autoantibodies and HLA genotype, more than high titers of glutamic acid decarboxylase autoantibodies, predict insulin dependence in latent autoimmune diabetes of adults.","volume":"163","author":"Maioli","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"2019041115285031400_B5","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1089\/152091502321118838","article-title":"Type 1 diabetes islet autoantibody markers.","volume":"4","author":"Winter","year":"2002","journal-title":"Diabetes Technol Ther"},{"key":"2019041115285031400_B6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.beem.2004.11.010","article-title":"Diabetes-related antibodies in adult diabetic patients.","volume":"19","author":"Falorni","year":"2005","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2019041115285031400_B7","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1046\/j.1365-2265.2000.00983.x","article-title":"Increased risk for endocrine autoimmunity in type 2 diabetic patients with GAD65 autoantibodies.","volume":"52","author":"Gambelunghe","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041115285031400_B8","doi-asserted-by":"crossref","first-page":"150","DOI":"10.2337\/diabetes.48.1.150","article-title":"Clinical and genetic characteristics of T2DM with and without GAD antibodies.","volume":"48","author":"Tuomi","year":"1999","journal-title":"Diabetes"},{"key":"2019041115285031400_B9","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-2265.2011.03976.x","article-title":"High titer of antiglutamic acid decarboxylase autoantibody is a strong predictor of the development of thyroid autoimmunity in patients with type 1 diabetes and latent autoimmune diabetes in adults.","volume":"74","author":"Jin","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041115285031400_B10","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1046\/j.1365-2265.1996.00857.x","article-title":"HLA DRB1\/DQA1\/DQB1 haplotype determines thyroid autoimmunity in patients with insulin-dependent diabetes mellitus.","volume":"45","author":"Chuang","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041115285031400_B11","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1210\/jcem-72-5-973","article-title":"Autosomal dominant inheritance of autoantibodies to thyroid peroxidase and thyroglobulin studies in families not selected for autoimmune thyroid disease.","volume":"72","author":"Phillips","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041115285031400_B12","doi-asserted-by":"crossref","first-page":"534","DOI":"10.2337\/dc07-1457","article-title":"The protein tyrosine phosphatase nonreceptor 22 (PTPN22) is associated with high GAD antibody titer in latent autoimmune diabetes in adults: Non-Insulin Requiring Autoimmune Diabetes (NIRAD) Study 3.","volume":"31","author":"Petrone","year":"2008","journal-title":"Diabetes Care"},{"key":"2019041115285031400_B13","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s001250050358","article-title":"Islet autoantibody markers in insulin dependent diabetes: risk assessment strategies yielding high sensitivity.","volume":"38","author":"Bonifacio","year":"1995","journal-title":"Diabetologia"},{"key":"2019041115285031400_B14","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.2337\/diabetes.52.5.1128","article-title":"Diabetes antibody standardization program: first assay proficiency evaluation.","volume":"52","author":"Bingley","year":"2003","journal-title":"Diabetes"},{"key":"2019041115285031400_B15","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.2337\/db07-0874","article-title":"Identification of tyrosine phosphatase 2(256\u2013760) construct as a new, sensitive marker for the detection of islet autoimmunity in type 2 diabetic patients: the Non-Insulin Requiring Autoimmune Diabetes (NIRAD) study 2.","volume":"57","author":"Tiberti","year":"2008","journal-title":"Diabetes"},{"key":"2019041115285031400_B16","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2337\/dc08-2305","article-title":"Zinc transporter 8 antibodies complement GAD and IA-2 antibodies in the identification and characterization of adult-onset autoimmune diabetes. Non-Insulin Requiring Autoimmune Diabetes (NIRAD) 4.","volume":"33","author":"Lampasona","year":"2010","journal-title":"Diabetes Care"},{"key":"2019041115285031400_B17","first-page":"2752","article-title":"High diagnostic accuracy for idiopathic Addison's disease with a sensitive radiobinding assay for autoantibodies against recombinant human 21-hydroxylase.","volume":"80","author":"Falorni","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041115285031400_B18","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1210\/jc.2009-1733","article-title":"Autoantibodies to insulin, insulinoma-associated antigen-2, and zinc transporter 8 improve the prediction of early insulin requirement in adult-onset autoimmune diabetes.","volume":"95","author":"Kawasaki","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041115285031400_B19","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.2337\/dc11-2081","article-title":"Zinc transporter-8 autoantibodies improve prediction of type 1 diabetes in relatives positive for the standard biochemical autoantibodies.","volume":"35","author":"Yu","year":"2012","journal-title":"Diabetes Care"},{"key":"2019041115285031400_B20","doi-asserted-by":"crossref","first-page":"17040","DOI":"10.1073\/pnas.0705894104","article-title":"The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes.","volume":"104","author":"Wenzlau","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041115285031400_B21","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1046\/j.1365-2249.2001.01668.x","article-title":"\u03b2-Cell, thyroid, gastric, adrenal and coeliac autoimmunity and HLA-DQ types in type 1 diabetes.","volume":"126","author":"De Block","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"2019041115285031400_B22","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/(SICI)1096-9136(199605)13:5<415::AID-DIA96>3.0.CO;2-X","article-title":"In new-onset insulin-dependent diabetic patients the presence of anti-thyroid peroxidase antibodies is associated with islet cell autoimmunity and the high risk haplotype HLA DQA1*0301-DQB1*0302. Belgian Diabetes Registry.","volume":"13","author":"Abrams","year":"1996","journal-title":"Diabet Med"},{"key":"2019041115285031400_B23","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/BF03401541","article-title":"Epidemiology of type 1 diabetes mellitus in Cyprus: rising incidence at the dawn of the 21st century.","volume":"11","author":"Skordis","year":"2012","journal-title":"Hormones (Athens)"},{"key":"2019041115285031400_B24","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/BF00400852","article-title":"Male predominance of type 1 (insulin-dependent) diabetes mellitus in young adults: results from a 5-year prospective nationwide study of the 15\u201334-year age group in Sweden.","volume":"35","author":"Blohm\u00e9","year":"1992","journal-title":"Diabetologia"},{"key":"2019041115285031400_B25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1046\/j.1365-2249.2003.02205.x","article-title":"Gliadin, endomysial and thyroid antibodies in patients with latent autoimmune diabetes of adults (LADA).","volume":"133","author":"Kucera","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"2019041115285031400_B26","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.2337\/diacare.17.12.1549","article-title":"IDDM and celiac disease.","volume":"17","author":"Schober","year":"1994","journal-title":"Diabetes Care"},{"key":"2019041115285031400_B27","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ecl.2003.12.007","article-title":"Celiac disease associated with Type 1 diabetes mellitus.","volume":"33","author":"Rewers","year":"2004","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2019041115285031400_B28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/08916930601118825","article-title":"Celiac disease associated antibodies in persons with latent autoimmune diabetes of adult and type 2 diabetes.","volume":"40","author":"S\u00e1nchez","year":"2007","journal-title":"Autoimmunity"},{"key":"2019041115285031400_B29","doi-asserted-by":"crossref","first-page":"202","DOI":"10.2337\/diabetes.49.2.202","article-title":"Maturation of the humoral autoimmune response to epitopes of GAD in preclinical childhood type 1 diabetes.","volume":"49","author":"Bonifacio","year":"2000","journal-title":"Diabetes"},{"key":"2019041115285031400_B30","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1172\/JCI30760","article-title":"Proinsulin: a unique autoantigen triggering autoimmune diabetes.","volume":"116","author":"You","year":"2006","journal-title":"J Clin Invest"},{"key":"2019041115285031400_B31","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1084\/jem.182.1.75","article-title":"Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis in the Sjl\/j mouse.","volume":"182","author":"McRae","year":"1995","journal-title":"J Exp Med"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/97\/10\/3759\/10782723\/jcem3759.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T01:36:10Z","timestamp":1555032970000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/97\/10\/3759\/2834530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,1]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,10,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2012-2037","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,1]]}}}